» Articles » PMID: 7233509

Donor Platelet Response and Product Quality Assurance in Plateletpheresis

Overview
Journal Transfusion
Specialty Hematology
Date 1981 May 1
PMID 7233509
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Retrospective analysis of 352 donors who underwent plateletpheresis at least four times, each using the Haemonetics Model 30 Blood Processor, indicated that a postpheresis platelet count of less than 100,000/microliter occurred in only 2.7 per cent of phereses. Restricting pheresis to those with a prepheresis platelet count of greater than 150,000/microliter would have lowered this to 1.3 per cent and eliminated only 3.7 per cent of donations. The donors' platelet counts returned to baseline approximately four days and rebounded above baseline eight to eleven days after pheresis. To minimize the chance of a donor having a postpheresis platelet count less than 100,000/microliter, the prepheresis platelet count should be greater than 150,000/microliter. A platelet count greater than 150,000/microliter immediately following the previous pheresis can be used instead of the prepheresis platelet count. The yield was related to the prepheresis platelet count, number of cycles, sex, type of procedure (platelet or platelet-leukapheresis), and the yield recorded during an individual's previous procedures. Seventy-five per cent of plateletpheresis products contained more than 3.3 x 10(11) platelets. This might be a satisfactory standard for quality assurance.

Citing Articles

Effect of donor parameters and cell separators on yield of apheresis platelet and their impact on corrected count increment in aplastic anemia patients.

Srivastava A, Yadav B, Das I, Katharia R, Chaudhary R, Rani P Asian J Transfus Sci. 2024; 17(2):246-250.

PMID: 38274965 PMC: 10807526. DOI: 10.4103/ajts.ajts_146_22.


Effect of plateletpheresis on postdonation serum thrombopoietin levels and its correlation with platelet counts in healthy voluntary donors.

Hans R, Sharma R, Marwaha N Asian J Transfus Sci. 2019; 13(1):10-16.

PMID: 31360004 PMC: 6580838. DOI: 10.4103/ajts.AJTS_86_18.


The argument(s) for lowering the US minimum required content of apheresis platelet components.

Benjamin R, Katz L, Gammon R, Stramer S, Quinley E Transfusion. 2018; 59(2):779-788.

PMID: 30461026 PMC: 7379583. DOI: 10.1111/trf.15036.


Recovery of Platelet Count among Apheresis Platelet Donors.

Thokala R, Radhakrishnan K, Anandan A, Panicker V J Clin Diagn Res. 2017; 10(12):EC01-EC04.

PMID: 28208861 PMC: 5296434. DOI: 10.7860/JCDR/2016/21070.8997.


Comparison of plateletpheresis on three continuous flow cell separators.

Tendulkar A, Rajadhyaksha S Asian J Transfus Sci. 2010; 3(2):73-7.

PMID: 20808650 PMC: 2920476. DOI: 10.4103/0973-6247.53877.